��Ƶ

A clinical trial for Aviptadil (RLF-100) is underway at UofL for severe COVID-19 patients. Image courtesy NeuroRx.

Advancing our Health

UofL conducting clinical trial on drug for severe COVID-19 respiratory effects

Baylee Pulliam - July 16, 2020

The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the...